Aytu BioPharma Inc. (AYTU) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Aytu BioPharma Inc.

NASDAQ: AYTU · Real-Time Price · USD
1.74
-0.12 (-6.45%)
At close: Sep 26, 2025, 3:59 PM
1.84
5.75%
After-hours: Sep 26, 2025, 07:59 PM EDT

Aytu BioPharma Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Net Income
-13.56M -15.84M -17.05M -110.17M -58.29M
Depreciation & Amortization
5.38M 8.27M 8.81M 10.25M 9.2M
Stock-Based Compensation
576K 2.91M 6.05M 5.25M 3.57M
Other Working Capital
1.23M -9.37M 2.58M -11.01M 596K
Other Non-Cash Items
11.4M 7.93M -403K 76.71M -4.46M
Deferred Income Tax
n/a n/a 3.26M n/a 22.33M
Change in Working Capital
-5.73M -4.66M -5.8M -10.86M 1.68M
Operating Cash Flow
-1.94M -1.39M -5.13M -28.82M -25.96M
Capital Expenditures
-228K n/a n/a n/a -2.34M
Cash Acquisitions
n/a n/a -5K -3.18M -2.82M
Purchase of Investments
n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a
Other Investing Acitivies
-2.33M -329K -112K -70K 2.38M
Investing Cash Flow
-2.56M -329K -117K -3.25M -2.78M
Debt Repayment
603K -1.89M -2.35M -5.22M -968K
Common Stock Repurchased
n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a -2.84M -4.36M -4.94M -8.87M
Financial Cash Flow
15.44M -1.26M 8.87M 1.53M 30.31M
Net Cash Flow
10.95M -2.98M 3.63M -30.54M 1.57M
Free Cash Flow
-2.17M -1.39M -5.13M -28.82M -28.3M